Jump to Main Content
Anti-elastolytic activity of a honeybee (Apis cerana) chymotrypsin inhibitor
- Kim, Bo Yeon, Lee, Kwang Sik, Wan, Hu, Zou, Feng Ming, Choi, Yong Soo, Yoon, Hyung Joo, Kwon, Hyung Wook, Je, Yeon Ho, Jin, Byung Rae
- Biochemical and biophysical research communications 2013 v.430 pp. 144-149
- Apis cerana, alternative medicine, cathepsin G, chymotrypsin, cysteine, elastase, honey bees, humans, neutrophils, plasmin, t-plasminogen activator, thrombin, trypsin, trypsin inhibitors
- The honeybee is an important insect species in global ecology, agriculture, and alternative medicine. While chymotrypsin and trypsin inhibitors from bees show activity against cathepsin G and plasmin, respectively, no anti-elastolytic role for these inhibitors has been elucidated. In this study, we identified an Asiatic honeybee (Apis cerana) chymotrypsin inhibitor (AcCI), which was shown to also act as an elastase inhibitor. AcCI was found to consist of a 65-amino acid mature peptide that displays ten cysteine residues. When expressed in baculovirus-infected insect cells, recombinant AcCI demonstrated inhibitory activity against chymotrypsin (Ki 11.27nM), but not trypsin, defining a role for AcCI as a honeybee-derived chymotrypsin inhibitor. Additionally, AcCI showed no detectable inhibitory effects on factor Xa, thrombin, plasmin, or tissue plasminogen activator; however, AcCI inhibited human neutrophil elastase (Ki 61.05nM), indicating that it acts as an anti-elastolytic factor. These findings constitute molecular evidence that AcCI acts as a chymotrypsin/elastase inhibitor.